Psychedelics Psilocybin access denied to patients despite ongoing lawsuit against Health Canada Eight patients sued the government at the end of July last year over what they believe is a violation of constitutional rights Rowan Dunne2 days ago
Psychedelics Apex Labs doses first patient in Veterans take-home psilocybin drug trial The development marks a 'watershed moment for psilocybin research' says the company's CEO Rowan DunneJanuary 18, 2023
Psychedelics Quebec becomes first province to pay doctors for psilocybin-assisted therapy Two physicians were paid by the provincial government for facilitating the therapy earlier this year Rowan DunneDecember 15, 2022
Canada TheraPsil launches Project Solace, Filament Health offers support 'Largest' psilocybin access and data campaign intended to forward mission of promoting fungi-assisted psychotherapy Rowan DunneJuly 28, 2022
Canada Psilocybin and craft cannabis farmers to gather in B.C. Meeting for Vancouver Island growers and community leaders to be held on June 16. Rowan DunneJune 9, 2022
Psychedelics U.S. psychedelic drug market to reach $8.9B by 2029: DBMR report As rates of mental health disorders increase the demand for psychedelic treatments do too Rowan DunneJune 6, 2022
Legalization Georgia advances bill to create psychedelic study group focused on Veterans’ mental health Lawmakers note that current therapeutic trials for substance use issues exclude people with a history of substance abuse Natalia Buendia CalvilloMarch 29, 2022
News Therapists’ personal experience important for patients undergoing psilocybin-assisted therapy: study Previous experience was rated more important than shared symptoms, gender or ethnicity Natalia Buendia CalvilloMarch 28, 2022
International Australian researchers granted $3M for psychedelic mental health treatments Two separate trials will look at MDMA for alcohol use and PTSD, as well as psilocybin-assisted therapy for anorexia nervosa Nick LabaJanuary 17, 2022
Canada ATMA to run clinical trial for synthetic psilocybin on medical professionals Following the trial's approval from Health Canada, psychedelic practitioners can now apply to be research subjects Natalia Buendia CalvilloJanuary 11, 2022